GL1X · GenesisL1 explorer

MolNFT v1 · #91798 · protein

Crystal structure of the R1275Q anaplastic lymphoma kinase catalytic domain in complex with a benzoxazole inhibitor

4FNY · ALK tyrosine kinase receptor: “Crystal structure of the R1275Q anaplastic lymphoma kinase catalytic domain in complex with a benzoxazole…”. X-ray diffraction, 1 ligand (I3K), 2 pockets (best druggability 0.69). MolNFT v1 #91798 on…

PDB
4FNY
Type
protein
Length
273 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
ALK tyrosine kinase receptor
EC
2.7.10.1
UniProt
Q9UM73
Ligands
I3K
Pockets
2 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AALK tyrosine kinase receptor (EC 2.7.10.1)protein27342% helix, 15% strandQ9UM73

Ligands and binding sites

  • I3K · N-(4-chlorophenyl)-5-[(6,7-dimethoxyquinolin-4-yl)oxy]-1,3-benzoxazol-2-amine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12510.690.8432I3K
2550.340.7813empty

Compared structures

  • 4FNY · Crystal structure of the R1275Q anaplastic lymphoma kinase catalytic domain in complex… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9UM73 · AlphaFold monomer V2.0 prediction for ALK tyrosine kinase receptor (Q9UM73) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.